Net Medical Xpress Solutions, Inc. (NMXS) Aktienanalyse
Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
NMXS steht fuer Net Medical Xpress Solutions, Inc., ein Healthcare-Unternehmen mit einem Kurs von $ (Marktkapitalisierung 0). Bewertet mit 39/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.
Zuletzt analysiert: 17. März 2026Net Medical Xpress Solutions, Inc. (NMXS) Gesundheitswesen & Pipeline-Uebersicht
Net Medical Xpress Solutions, Inc. delivers telemedicine solutions, including its Telemed platform, to hospitals and nursing homes, specializing in areas like teleneurology and telecardiology. Operating in the healthcare information services sector, the company integrates with existing EMR systems to enhance remote patient care and physician support.
Investmentthese
Net Medical Xpress Solutions, Inc. operates in the growing telemedicine market, but its financial performance raises concerns. With a negative profit margin of -311.1% and a negative gross margin of -10.1%, the company's profitability is a significant challenge. The company's Telemed platform and integration services could drive future growth, but the current financial metrics suggest a need for improved operational efficiency and revenue generation. The company's small size (23 employees) and OTC listing add to the risk profile. Investors should closely monitor the company's ability to improve its financial performance and capitalize on the telemedicine market's growth potential.
Basierend auf FMP-Finanzdaten und quantitativer Analyse
Wichtige Highlights
- Market Cap of $0.00B indicates a micro-cap company with limited financial resources.
- P/E Ratio of -0.01 suggests the company is not currently profitable.
- Profit Margin of -311.1% reflects significant losses relative to revenue.
- Gross Margin of -10.1% indicates that the company's cost of goods sold exceeds its revenue.
- Beta of -1.85 suggests the stock price moves inversely to the market, and with greater volatility.
Wettbewerber & Vergleichsunternehmen
Staerken
- Specialized telemedicine services in areas like teleneurology and telecardiology.
- Proprietary Telemed platform offering customizable telemedicine management.
- Integration capabilities with approximately 43 hospital-based EMR systems.
- Offers a range of services including staffing, recruiting, and diagnostic services.
Schwaechen
- Negative profit margin and gross margin indicate financial instability.
- Small market capitalization limits access to capital.
- Limited number of employees (23) may constrain growth potential.
- OTC listing increases risk and reduces liquidity.
Katalysatoren
- Ongoing: Expansion of telemedicine services into new medical specialties.
- Ongoing: Strategic partnerships with hospitals and healthcare systems.
- Ongoing: Development of remote patient monitoring solutions.
- Upcoming: Potential integration of AI and machine learning into the Telemed platform.
- Upcoming: Geographic expansion into international markets.
Risiken
- Ongoing: Negative profit margin and gross margin indicate financial instability.
- Ongoing: Small market capitalization limits access to capital.
- Potential: Intense competition from established telemedicine providers.
- Potential: Evolving regulatory landscape for telemedicine.
- Potential: Cybersecurity risks associated with remote healthcare delivery.
Wachstumschancen
- Expansion of Telemedicine Services: The telemedicine market is experiencing substantial growth, driven by increased demand for remote patient monitoring and virtual consultations. Net Medical Xpress Solutions can capitalize on this trend by expanding its Telemed platform's capabilities and targeting new medical specialties. By offering specialized telemedicine solutions for areas like dermatology or mental health, the company can attract new clients and increase revenue streams. The global telemedicine market is projected to reach $460 billion by 2030, presenting a significant opportunity for growth.
- Strategic Partnerships with Hospitals and Healthcare Systems: Collaborating with hospitals and healthcare systems can provide Net Medical Xpress Solutions with access to a broader patient base and established referral networks. By integrating its Telemed platform with existing hospital EMR systems, the company can streamline workflows and improve patient care coordination. These partnerships can also lead to long-term contracts and recurring revenue streams. Focus on hospitals in rural areas or with limited access to specialists could be a particularly effective strategy.
- Development of Remote Patient Monitoring Solutions: Remote patient monitoring (RPM) is a rapidly growing segment of the telemedicine market, enabling healthcare providers to track patients' vital signs and health data remotely. Net Medical Xpress Solutions can develop and offer RPM solutions that integrate with its Telemed platform, allowing for real-time monitoring and proactive intervention. This can improve patient outcomes, reduce hospital readmissions, and generate additional revenue. The RPM market is projected to reach $178.5 billion by 2027.
- Geographic Expansion: Net Medical Xpress Solutions currently focuses on the US market. Expanding into international markets, particularly in regions with limited access to healthcare, can provide significant growth opportunities. Adapting the Telemed platform to meet the specific needs and regulatory requirements of different countries will be crucial for success. Focusing on countries with government initiatives to promote telemedicine adoption could be a strategic approach.
- Integration of Artificial Intelligence (AI) and Machine Learning (ML): Incorporating AI and ML technologies into the Telemed platform can enhance its capabilities and improve patient outcomes. AI-powered diagnostic tools, personalized treatment recommendations, and automated administrative tasks can streamline workflows and reduce costs. By leveraging AI and ML, Net Medical Xpress Solutions can differentiate itself from competitors and attract clients seeking innovative telemedicine solutions. The AI in healthcare market is projected to reach $95 billion by 2030.
Chancen
- Growing demand for telemedicine services driven by increasing healthcare costs and access challenges.
- Expansion into new medical specialties and geographic markets.
- Development of remote patient monitoring solutions.
- Integration of AI and machine learning to enhance the Telemed platform.
Risiken
- Intense competition from established telemedicine providers.
- Evolving regulatory landscape for telemedicine.
- Potential cybersecurity risks associated with remote healthcare delivery.
- Reimbursement challenges for telemedicine services.
Wettbewerbsvorteile
- Proprietary Telemed Platform: The Telemed platform provides a customizable telemedicine management system.
- Integration Capabilities: Integration with approximately 43 hospital-based EMR systems creates switching costs for customers.
- Specialized Telemedicine Services: Focus on specific areas like teleneurology and telecardiology provides expertise and differentiation.
- FDA-Cleared Image Viewers: FDA clearance provides a level of credibility and regulatory compliance.
Ueber NMXS
Founded in 1995 and based in Albuquerque, New Mexico, Net Medical Xpress Solutions, Inc., formerly known as New Mexico Software, Inc., has evolved into a telemedicine solutions provider. The company's core offering is its Telemed platform, a customizable telemedicine management system designed for hospitals, nursing homes, specialty hospitals, and other medical facilities. This platform supports a range of services, including teleneurology, teleneurosurgery, telecardiology, teleorthopedics, telewoundcare, and telenephrology. Net Medical Xpress Solutions provides a suite of tools and services, including digital paper, a development engine, single pane of glass software, and FDA-cleared image viewers. The company emphasizes integration, offering connectivity with approximately 43 hospital-based EMR systems. Beyond its technology platform, Net Medical Xpress Solutions provides physicians, administrative services (credentialing, program management, and call center management), and integration services such as electronic prescription software, prior authorization software, laboratory services, malpractice insurance, large-scale provider scheduling, medical translation, and rounding services. Additionally, the company offers staffing and recruiting services, diagnostic and clinical services, and Amazon cloud services. Net Medical Xpress Solutions aims to provide a comprehensive telemedicine solution, addressing both the technological and operational aspects of remote healthcare delivery.
Was das Unternehmen tut
- Provides a Telemed telemedicine platform for customized telemedicine management.
- Offers teleneurology, teleneurosurgery, telecardiology, teleorthopedics, telewoundcare, and telenephrology services.
- Develops digital paper, development engine, and single pane of glass software.
- Offers FDA-cleared image viewers.
- Integrates with approximately 43 hospital-based EMR systems.
- Provides telemedicine video conferencing equipment and USB clinical tools.
- Offers administrative services, such as credentialing, program management, and call center management.
Geschaeftsmodell
- Software as a Service (SaaS): Charges subscription fees for access to the Telemed platform.
- Service Fees: Generates revenue from providing telemedicine services, such as teleneurology and telecardiology.
- Integration Services: Earns revenue from integrating the Telemed platform with hospital EMR systems and other healthcare IT solutions.
- Staffing and Recruiting: Offers staffing and recruiting services for medical professionals.
Branchenkontext
Net Medical Xpress Solutions operates within the healthcare information services industry, a sector experiencing growth due to increasing demand for remote patient monitoring and telehealth solutions. The telemedicine market is projected to continue expanding as healthcare providers seek to improve access, reduce costs, and enhance patient outcomes. However, the industry is competitive, with established players and emerging startups vying for market share. Net Medical Xpress Solutions faces competition from companies like BBLNF (BioAdaptives, Inc.), CVHIF (CareView Communications, Inc.), CYPS (Cypsa), EMGE (Emageon), and LCDX (Lucidia Health), each offering various telemedicine solutions and services.
Wichtige Kunden
- Hospitals
- Nursing Homes
- Specialty Hospitals
- Other Medical Facilities
Finanzdaten
Chart & Info
Net Medical Xpress Solutions, Inc. (NMXS) Aktienkurs: Price data unavailable
Aktuelle Nachrichten
Keine aktuellen Nachrichten fuer NMXS verfuegbar.
Analystenkonsens
Konsens-Bewertung
Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer NMXS.
Kursziele
Wall-Street-Kurszielanalyse fuer NMXS.
MoonshotScore
Was bedeutet diese Bewertung?
Der MoonshotScore bewertet das Wachstumspotenzial von NMXS auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.
Fuehrung: Teresa Dickey
CEO
Teresa Dickey serves as the CEO of Net Medical Xpress Solutions, Inc. Her background includes extensive experience in managing and growing technology-driven companies. She has a proven track record in strategic planning, business development, and operational management. Her leadership is focused on driving innovation and expanding the company's reach in the telemedicine market. She is responsible for overseeing all aspects of the company's operations, from product development to sales and marketing.
Erfolgsbilanz: Under Teresa Dickey's leadership, Net Medical Xpress Solutions has focused on expanding its Telemed platform and integrating it with various hospital EMR systems. She has also overseen the development of new telemedicine services and the expansion into new geographic markets. Her strategic decisions have aimed to position the company as a leading provider of telemedicine solutions. She manages 23 employees.
NMXS OTC-Marktinformationen
The OTC Other tier, also known as the Pink Market, represents the lowest tier of over-the-counter (OTC) stocks. Companies in this tier often have limited or no financial reporting requirements, making it difficult for investors to assess their financial health and operational performance. Listing on the OTC Other tier is typically associated with higher risk compared to stocks listed on major exchanges like the NYSE or NASDAQ, due to the lack of regulatory oversight and transparency. These companies may be early-stage ventures, financially distressed entities, or foreign companies with limited US presence.
- OTC-Stufe: OTC Other
- Offenlegungsstatus: Unknown
- Limited Financial Disclosure: Lack of regular financial reporting increases the difficulty of assessing the company's financial health.
- Low Liquidity: Low trading volume and wide bid-ask spreads can make it difficult to buy or sell shares.
- Increased Volatility: OTC stocks are generally more volatile than those listed on major exchanges.
- Potential for Fraud or Manipulation: The lack of regulatory oversight increases the risk of fraudulent or manipulative activities.
- Going Concern Risk: Companies on the OTC Other tier may be facing financial difficulties and have a higher risk of going out of business.
- Verify the company's registration and legal standing.
- Obtain and review any available financial statements.
- Assess the company's business model and competitive landscape.
- Evaluate the management team's experience and track record.
- Research any past legal or regulatory issues.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- FDA clearance for image viewers suggests regulatory compliance.
- Integration with approximately 43 hospital-based EMR systems indicates market acceptance.
- Presence of a CEO (Teresa Dickey) and a management team.
- Years in business since 1995 suggests some level of operational history.
- Focus on telemedicine, a growing and potentially lucrative market.
NMXS Healthcare Aktien-FAQ
What are the key factors to evaluate for NMXS?
Net Medical Xpress Solutions, Inc. (NMXS) currently holds an AI score of 39/100, indicating low score. Key strength: Specialized telemedicine services in areas like teleneurology and telecardiology.. Primary risk to monitor: Ongoing: Negative profit margin and gross margin indicate financial instability.. This is not financial advice.
How frequently does NMXS data refresh on this page?
NMXS prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven NMXS's recent stock price performance?
Recent price movement in Net Medical Xpress Solutions, Inc. (NMXS) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Specialized telemedicine services in areas like teleneurology and telecardiology.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider NMXS overvalued or undervalued right now?
Determining whether Net Medical Xpress Solutions, Inc. (NMXS) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying NMXS?
Before investing in Net Medical Xpress Solutions, Inc. (NMXS), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding NMXS to a portfolio?
Potential reasons to consider Net Medical Xpress Solutions, Inc. (NMXS) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Specialized telemedicine services in areas like teleneurology and telecardiology.. Additionally: Proprietary Telemed platform offering customizable telemedicine management.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.
Can I buy fractional shares of NMXS?
Yes, most major brokerages offer fractional shares of Net Medical Xpress Solutions, Inc. (NMXS) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track NMXS's earnings and financial reports?
Net Medical Xpress Solutions, Inc. (NMXS) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for NMXS earnings announcements is recommended.
Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.
Offizielle Ressourcen
Daten dienen ausschliesslich zu Informationszwecken.
- Limited information available on OTC-listed companies.
- Financial data may not be fully up-to-date.